brain dead. Other specified disorders of central nervous system
Conditions
Interventions
Intervention 1: Intervention group: 100 mg of testosterone enanthate drug (manufactured by Caspian Tamin Company) was prepared by nurse of the intensive care department according to the grouping of th
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Brain dead patients aged 18-60 years are candidates for organ donation
Exclusion criteria
Exclusion criteria: Patients who have high blood pressure and do not need inotropes Hemodynamically unstable patients who will undergo organ donation surgery in less than 6 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dosage of noradrenaline. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: milliliters per hour.;Peripheral vascular resistance. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cardiac output. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor.;Cardiac Index. Timepoint: At the beginning of the patient's entry into the study and 8 hours after drug injection. Method of measurement: By Ultrasonic Cardiac Output Monitor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Reza Khajavi
Tehran University of Medical Sciences
Outcome results
None listed